146 related articles for article (PubMed ID: 11943937)
1. Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.
Asakura H; Ichino T; Yoshida T; Suga Y; Ontachi Y; Mizutani T; Kato M; Ito T; Yamazaki M; Aoshima K; Morishita E; Saito M; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):233-9. PubMed ID: 11943937
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.
Asakura H; Aoshima K; Ichino T; Suga Y; Saito M; Morishita E; Yamazaki M; Ontachi Y; Mizutani T; Kato M; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2001 Jun; 12(4):301-6. PubMed ID: 11460014
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
5. Induction of vasoactive substances differs in LPS-induced and TF-induced DIC models in rats.
Asakura H; Okudaira M; Yoshida T; Ontachi Y; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Thromb Haemost; 2002 Oct; 88(4):663-7. PubMed ID: 12362240
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
7. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
Asakura H; Sano Y; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Intensive Care Med; 2004 Oct; 30(10):1950-5. PubMed ID: 15480547
[TBL] [Abstract][Full Text] [Related]
9. Relationship between endothelin and the pathophysiology of tissue factor-induced and lipopolysaccharide-induced disseminated intravascular coagulation in rats: a study examining the effect of an endothelin receptor antagonist.
Suga Y; Asakura H; Yoshida T; Omote M; Ontachi Y; Mizutani T; Yamazaki M; Morishita E; Nakao S; Miyamoto K
Blood Coagul Fibrinolysis; 2004 Oct; 15(7):593-8. PubMed ID: 15389127
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
11. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
[TBL] [Abstract][Full Text] [Related]
12. Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
Tazawa S; Ichikawa K; Misawa K; Fukuyama J; Hamano S; Miyata H; Sakuragawa N
Thromb Res; 1995 Dec; 80(5):391-8. PubMed ID: 8588200
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals.
Hayashi M; Matsuo A; Nakamoto H; Aisaka K
Eur J Pharmacol; 2001 Jan; 412(1):61-6. PubMed ID: 11166737
[TBL] [Abstract][Full Text] [Related]
14. Effects of activated factor X inhibitor, JTV-803, in a pig model of hemodialysis.
Hayashi M; Uesato N; Aisaka K
Thromb Res; 2002 Sep; 107(6):351-6. PubMed ID: 12565723
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
[TBL] [Abstract][Full Text] [Related]
17. Antagonism by salvianolic acid B of lipopolysaccharide-induced disseminated intravascular coagulation in rabbits.
Wu Z; Li JN; Bai ZQ; Lin X
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):502-8. PubMed ID: 24739088
[TBL] [Abstract][Full Text] [Related]
18. Heparin blunts endotoxin-induced coagulation activation.
Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
[TBL] [Abstract][Full Text] [Related]
19. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
20. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
Izutani W; Fujita M; Nishizawa K; Koga J
Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
